Yang Jingzhou, Zhang Yu Shrike, Yue Kan, Khademhosseini Ali
Biomaterials Innovation Research Center, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02115, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Guangzhou Women and Children's Medical Center, Sun Yat-sen University, Guangzhou 510623, Guangdong, People's Republic of China.
Biomaterials Innovation Research Center, Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02115, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Acta Biomater. 2017 Jul 15;57:1-25. doi: 10.1016/j.actbio.2017.01.036. Epub 2017 Jan 11.
Despite tremendous advances in the field of regenerative medicine, it still remains challenging to repair the osteochondral interface and full-thickness articular cartilage defects. This inefficiency largely originates from the lack of appropriate tissue-engineered artificial matrices that can replace the damaged regions and promote tissue regeneration. Hydrogels are emerging as a promising class of biomaterials for both soft and hard tissue regeneration. Many critical properties of hydrogels, such as mechanical stiffness, elasticity, water content, bioactivity, and degradation, can be rationally designed and conveniently tuned by proper selection of the material and chemistry. Particularly, advances in the development of cell-laden hydrogels have opened up new possibilities for cell therapy. In this article, we describe the problems encountered in this field and review recent progress in designing cell-hydrogel hybrid constructs for promoting the reestablishment of osteochondral/cartilage tissues. Our focus centers on the effects of hydrogel type, cell type, and growth factor delivery on achieving efficient chondrogenesis and osteogenesis. We give our perspective on developing next-generation matrices with improved physical and biological properties for osteochondral/cartilage tissue engineering. We also highlight recent advances in biomanufacturing technologies (e.g. molding, bioprinting, and assembly) for fabrication of hydrogel-based osteochondral and cartilage constructs with complex compositions and microarchitectures to mimic their native counterparts.
Despite tremendous advances in the field of regenerative medicine, it still remains challenging to repair the osteochondral interface and full-thickness articular cartilage defects. This inefficiency largely originates from the lack of appropriate tissue-engineered biomaterials that replace the damaged regions and promote tissue regeneration. Cell-laden hydrogel systems have emerged as a promising tissue-engineering platform to address this issue. In this article, we describe the fundamental problems encountered in this field and review recent progress in designing cell-hydrogel constructs for promoting the reestablishment of osteochondral/cartilage tissues. Our focus centers on the effects of hydrogel composition, cell type, and growth factor delivery on achieving efficient chondrogenesis and osteogenesis. We give our perspective on developing next-generation hydrogel/inorganic particle/stem cell hybrid composites with improved physical and biological properties for osteochondral/cartilage tissue engineering. We also highlight recent advances in biomanufacturing and bioengineering technologies (e.g. 3D bioprinting) for fabrication of hydrogel-based osteochondral and cartilage constructs.
尽管再生医学领域取得了巨大进展,但修复骨软骨界面和全层关节软骨缺损仍然具有挑战性。这种低效率很大程度上源于缺乏能够替代受损区域并促进组织再生的合适的组织工程人工基质。水凝胶正在成为一类用于软组织和硬组织再生的有前途的生物材料。水凝胶的许多关键特性,如机械刚度、弹性、含水量、生物活性和降解性,可以通过适当选择材料和化学方法进行合理设计和方便调节。特别是,载细胞水凝胶的发展为细胞治疗开辟了新的可能性。在本文中,我们描述了该领域遇到的问题,并综述了设计细胞 - 水凝胶混合构建体以促进骨软骨/软骨组织重建的最新进展。我们的重点集中在水凝胶类型、细胞类型和生长因子递送对实现高效软骨生成和成骨的影响上。我们对开发具有改善的物理和生物学特性的下一代基质用于骨软骨/软骨组织工程发表了看法。我们还强调了生物制造技术(如模塑、生物打印和组装)在制造具有复杂组成和微结构以模拟其天然对应物的基于水凝胶的骨软骨和软骨构建体方面的最新进展。
尽管再生医学领域取得了巨大进展,但修复骨软骨界面和全层关节软骨缺损仍然具有挑战性。这种低效率很大程度上源于缺乏能够替代受损区域并促进组织再生的合适的组织工程生物材料。载细胞水凝胶系统已成为解决这一问题的有前途的组织工程平台。在本文中,我们描述了该领域遇到的基本问题,并综述了设计细胞 - 水凝胶构建体以促进骨软骨/软骨组织重建的最新进展。我们的重点集中在水凝胶组成、细胞类型和生长因子递送对实现高效软骨生成和成骨的影响上。我们对开发具有改善的物理和生物学特性的下一代水凝胶/无机颗粒/干细胞混合复合材料用于骨软骨/软骨组织工程发表了看法。我们还强调了生物制造和生物工程技术(如3D生物打印)在制造基于水凝胶的骨软骨和软骨构建体方面的最新进展。